“It has been a busy time in acne drug development leading to the availability of new topical and oral products across the spectrum of medication categories used to treat acne,” says Lawrence F. Eichenfield, M.D.
Read insights from James Q. Del Rosso, D.O., as he discusses antibiotic resistance, isotretinoin relapse, and laboratory monitoring for patients on isotretinoin and spironolactone.
